1.90% 0.02

Adial Pharmaceuticals Inc (ADIL)

Panoramica Notizia Cronologia dei prezzi Financials Perché ADIL Giù? Forum Previsione Frazionamento azionario

Adial Pharmaceuticals Inc Azioni (ADIL) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	3.43% 1.845	1.7838	1.3579	0.2227	2.9207
Operating Income/Loss	3.43% -1.845	-1.7838	-1.3579	-1.4774	-2.9207
Nonoperating Income/Loss	3,741% -4.6315	-0.1206	0.0102	-0.0325	0.0149
Income/Loss Before Equity Method Investments	-6.2867	-	-	-	-
Income/Loss From Equity Method Investments	-0.1899	-	-	-	-
Income/Loss From Continuing Operations Before Tax	240.08% -6.4766	-1.9044	-1.3477	-1.5099	-2.9058
Income/Loss From Continuing Operations After Tax	240.08% -6.4766	-1.9044	-1.3477	-1.5099	-2.9058
Net Income/Loss	237.26% -6.4766	-1.9203	-1.385	1.0878	-2.9058
Preferred Stock Dividends And Other Adjustments	-	-	-	0.868	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Diluted Average Shares	873.82% 2.9539	0.3033	1.1785	1.1314	26.46
Basic Earnings Per Share	195.95% -2.19	-0.74	-1.18	0.96	-0.11
Diluted Earnings Per Share	195.95% -2.19	-0.74	-1.18	0.96	-0.11
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	0.868	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%